I am working on the clinical applications of the blood-based protein biomarkers in the diagnosis and the outcome prediction of TBIs. The theme of my project is: "Combining neuroimaging and blood biomarkers in the assessment of traumatic brain injuries."

The project has been awarded as the best neurosurgical research project in the field of TBI by the European Association of Neurosurgical Societies (EANS) in 2018.

Our multicentre (Finland, UK, Sweden and Switzerland) based traumatic brain injury research group has been working on the correlation between the blood biomarkers and the imaging tools to develop a novel approach for the proper diagnosis, treatment and follow-up evaluation of patients with TBI. The findings of the first manuscript and the theme of the doctoral thesis have been presented in the 7th International Conference on Biochemical Markers for Brain Damage (BMBD) 2015, Lund, Sweden and in the 6th South Asian Neurosurgical Congress 2016, Dhaka, Bangladesh by the doctoral candidate. The novel idea for developing new diagnostic tools for TBI were also reported by the doctoral candidate in the 3rd Chinese Neurology and Neurosurgery Conference in December 2016. Moreover, the findings of the second manuscript have been highly appreciated in the 12th World Congress on Brain Injury, March, 2017, New Orleans, USA and was presented also in the 17th European Neurosurgical Congress 2017, October, Venice, Italy as an oral presentation by the doctoral candidate. Doctoral candidate has successfully presented the latest promising results of the third manuscript of his thesis project in the 18th Annual Congress of the EANS in October, 2018 in Brussels, Belgium. It is expected that this doctoral thesis will provide excellent evidence for the utility of these biomarkers in the field of TBI diagnostics. Furthermore, it will also bring new collaborations in the fields of TBI research.